These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21647865)

  • 1. Cigarette smoking is not a risk factor for systemic sclerosis.
    Chaudhary P; Chen X; Assassi S; Gorlova O; Draeger H; Harper BE; Gonzalez E; McNearney T; Perry M; Arnett FC; Mayes MD
    Arthritis Rheum; 2011 Oct; 63(10):3098-102. PubMed ID: 21647865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis.
    Gourh P; Tan FK; Assassi S; Ahn CW; McNearney TA; Fischbach M; Arnett FC; Mayes MD
    Arthritis Rheum; 2006 Dec; 54(12):3945-53. PubMed ID: 17133608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.
    Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA;
    Arthritis Rheumatol; 2018 Nov; 70(11):1829-1834. PubMed ID: 29781588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.
    Ciaffi J; Liem SIE; Cannegieter S; Ahmed S; Hoekstra EM; Wiland P; Atsumi T; Szücs G; Balbir Gurman A; Czirják L; Zanatta E; Koetter I; Henes JC; Matucci-Cerinic M; Airò P; Ursini F; Huizinga TWJ; De Vries-Bouwstra J; Collaborators E
    RMD Open; 2024 May; 10(2):. PubMed ID: 38772679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.
    Nguyen B; Mayes MD; Arnett FC; del Junco D; Reveille JD; Gonzalez EB; Draeger HT; Perry M; Hendiani A; Anand KK; Assassi S
    Arthritis Rheum; 2011 Feb; 63(2):530-4. PubMed ID: 21280007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis.
    Harrison BJ; Silman AJ; Hider SL; Herrick AL
    Arthritis Rheum; 2002 Dec; 46(12):3312-6. PubMed ID: 12483737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis.
    Kuwana M; Inoko H; Kameda H; Nojima T; Sato S; Nakamura K; Ogasawara T; Hirakata M; Ohosone Y; Kaburaki J; Okano Y; Mimori T
    Intern Med; 1999 Apr; 38(4):336-44. PubMed ID: 10361906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort.
    Ciaffi J; van Leeuwen NM; Huizinga TWJ; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):25-28. PubMed ID: 32242801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of an Extended Autoantibody Profile in a Well-Characterized Australian Systemic Sclerosis (Scleroderma) Cohort Using Principal Components Analysis.
    Patterson KA; Roberts-Thomson PJ; Lester S; Tan JA; Hakendorf P; Rischmueller M; Zochling J; Sahhar J; Nash P; Roddy J; Hill C; Nikpour M; Stevens W; Proudman SM; Walker JG
    Arthritis Rheumatol; 2015 Dec; 67(12):3234-44. PubMed ID: 26246178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cigarette smoking mitigate the severity of skin disease in systemic sclerosis?
    Gyger G; Hudson M; Lo E; Steele R; ; Baron M
    Rheumatol Int; 2013 Apr; 33(4):943-8. PubMed ID: 22829414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
    Miyake M; Matsushita T; Takehara K; Hamaguchi Y
    Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.
    Foocharoen C; Watcharenwong P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R
    Int J Rheum Dis; 2017 Oct; 20(10):1572-1581. PubMed ID: 28296274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-topoisomerase I antibodies in silica-associated systemic sclerosis. A model for autoimmunity.
    McHugh NJ; Whyte J; Harvey G; Haustein UF
    Arthritis Rheum; 1994 Aug; 37(8):1198-205. PubMed ID: 8053959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.